A comparative assessment on the effectiveness of paracervical block and rectal diclofenac for pain relief during diagnostic hysteroscopy.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202303663072593

Enrollment

100

Registered

2023-03-22

Start date

2023-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Paracervical block group

Rectal Diclofenac group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: ?Women undergoing diagnostic hysteroscopy and gave consent for the study

Exclusion criteria

Exclusion criteria: 1.Women who are allergic to lignocaine/diclofenac 2.Women who had failed attempts at previous hysteroscopy 3.Women with cervicitis or active pelvic inflammatory disease

Design outcomes

Primary

Measure	Time frame
The primary outcome, measured the mean pain scores in the participants who will receive rectal diclofenac or PCB during diagnostic hysteroscopy	—

Secondary

Measure	Time frame
1.patient satisfaction 2.Side effects during diagnostic hysteroscopy	—

Countries

Nigeria

Contacts

Public ContactHyginus Ezegwui

Professor

hyginus.ezegwui@unn.edu.ng+2347030489009

Outcome results